Response rates to a mailed survey of a representative sample of cancer patients randomly drawn from the Pennsylvania Cancer Registry: a randomized trial of incentive and length effects by Kelly, Bridget J et al.
Kelly et al. BMC Medical Research Methodology 2010, 10:65
http://www.biomedcentral.com/1471-2288/10/65
Open Access RESEARCH ARTICLE
© 2010 Kelly et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Research article Response rates to a mailed survey of a 
representative sample of cancer patients randomly 
drawn from the Pennsylvania Cancer Registry: a 
randomized trial of incentive and length effects
Bridget J Kelly*1, Taressa K Fraze2 and Robert C Hornik2
Abstract
Background: In recent years, response rates to telephone surveys have declined. Online surveys may miss many older 
and poorer adults. Mailed surveys may have promise in securing higher response rates.
Methods: In a pilot study, 1200 breast, prostate and colon patients, randomly selected from the Pennsylvania Cancer 
Registry, were sent surveys in the mail. Incentive amount ($3 vs. $5) and length of the survey (10 pages vs. 16 pages) 
were randomly assigned.
Results: Overall, there was a high response rate (AAPOR RR4 = 64%). Neither the amount of the incentive, nor the 
length of the survey affected the response rate significantly. Colon cancer surveys were returned at a significantly lower 
rate (RR4 = 54%), than breast or prostate surveys (RR4 = 71%, and RR4 = 67%, respectively; p < .001 for both 
comparisons). There were no significant interactions among cancer type, length of survey and incentive amount in 
their effects on response likelihood.
Conclusion: Mailed surveys may provide a suitable alternative option for survey-based research with cancer patients.
Background
In the last several years, researchers have reported declin-
ing response rates to telephone surveys across many areas
of study [1-5]. While Web-based surveys are becoming
increasingly popular as an alternative because they have
been shown to result in quicker responses than mailed
surveys, average response rates are not high [6]. In addi-
tion, their administration can be expensive and the repre-
sentativeness of many Internet population frames is
problematic [7]. There is evidence in the literature that
some populations are less likely to use the Internet. For
example, those over age 55 are still less likely to use the
Internet than their younger counterparts [8,9]. Internet
surveys may also miss those of lower socio-economic sta-
tus [7].
Phone surveys are typically more expensive than either
mailed or web surveys, as they require trained interview-
ers to make the calls. Research comparing modes has
found that telephone surveys result in higher likelihood
of obtaining extreme positive results due to recency
effects [10]. In addition, traditional sampling using RDD
methods has faced increasing challenges as more house-
holds rely primarily on cell-phones [11,12]. As a result,
some research shows that response rates for mailed sur-
veys can be much higher than those administered by
phone or Internet [6,13,14].
Given the advantage over web surveys in coverage and
the potential cost savings compared to phone surveys, we
were interested in using a mailed survey to collect data
from patients with three types of cancers. The purpose of
the following study was to test the feasibility of using a
mailed survey to gather information from recently diag-
nosed cancer patients, and to test whether specific proce-
dures would affect response rates. We piloted mailed
survey methods on a sample of 1,200 cancer patients ran-
domly chosen from the Pennsylvania Cancer Registry and
experimented with several strategies to determine how to
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achieve the highest response rate for the lowest cost. Two
different incentive amounts ($3 and $5) and two survey
lengths (33 questions--or 10 pages--and 61 questions--or
16 pages) were tested with breast, prostate and colon can-
cer patients.
Increasing response rates
Much research has investigated the effects of manipulat-
ing specific features (i.e., anonymity; the color; number of
follow-up mailings) of a mailed survey to increase
response rates or reduce non-response bias [15-28]. One
of the most frequently studied features is the inclusion of
monetary incentives [17-19]. While there is evidence for
the benefit of using incentives [15,17,19-23], researchers
have not yet determined an ideal denomination [24].
Some researchers have found that the increase in
response rate is not necessarily monotonically related to
incentive amount [18,24-26]. Warriner et al. (1996) found
$5 to be more effective than $2, but no less effective than
$10 [27]. James & Bolstein (1992) showed that response
rates increased from $.25 to $.50 and from $.50 to $1, but
not between $1 and $2 [18]. In a meta-analysis of ran-
domized controlled trials of monetary incentives,
Edwards, Cooper, Roberts and Frost found that the
pooled odds ratios for response per $.01 of incentive
decreased monotonically as the maximum amount of
incentive increased [22]. Dillman provides a theoretical
explanation, which suggests that incentive amounts have
diminishing returns as the amount approaches the actual
value of the service being performed, at which point peo-
p l e  p e r c e i v e  a n s w e r i n g  t h e  s u rv e y  a s  m o r e  o f  a n  e c o -
nomic exchange than a social exchange and have an
easier time refusing the money [28].
A second feature manipulated was the length of the
survey. Studies on the effect of length on response rates
have had mixed results [29]. Some studies, including a
review of 200 surveys on patient satisfaction have found
no effect [17,30-32]. However, in studies in which the dif-
ference between two survey versions was more dramatic,
significant effects have resulted [28,33,34]. Two meta
analyses of clinical trials found that shorter question-
naires increased the likelihood of response [35,36]. How-
ever, Edwards, Roberts, Sandercock & Frost (2004) found
that the effects were larger when the questionnaire was
short to begin with (which is not the case in this study).
It was also likely that there would be differences in
return rates between the three types of cancer. There is
not much guidance in the literature about whether
patients with one type of cancer might be more likely to
respond than others, as the majority of surveys focus on
one type of cancer. While a recent study did find that
breast cancer patients responded at a higher rate than
those with prostate or colon cancer, this study had not
been published at the time we were designing our experi-
ment [37]. It is also possible that any of these three factors
(incentive, survey length and cancer type) may interact to
affect response rates.
And lastly, media coverage of specific cancers, gender
differences [38-40], age [39], and disease severity/charac-
teristics [40] are all factors that could potentially affect
response rates. Some researchers have argued that the
effects of incentives may be contingent upon demo-
graphic group [41,42].
Based on the literature and this logic, this study
included a number of hypotheses and research questions.
The hypotheses included: A $5 incentive will result in
higher response rates than a $3 incentive; a longer survey
w i l l  h a v e  a  l o w e r  r e s p o n s e  r a t e  t h a n  a  s h o r t e r  s u rv e y .
Research questions included: How will response rates dif-
fer by type of cancer? Will length of survey and incentive
amount interact with each other or with type of cancer in
affecting response rate? Will incentive amount interact
with specific demographic characteristics, such as race or
marital status?
Methods
Participants
The sample was drawn from the entire population of
patients with cancers of the breast (females only), pros-
tate (males only) or colon (males and females), reported
to the Pennsylvania Cancer Registry in 2005 in time to
have their data compiled by July of 2006 (approximately
55% of the total number of incident cases in 2005, which
was 20,200 across the three cancers; see Figure 1). The
age range was not restricted. A sample of 400 people was
randomly chosen for each of the three cancers. This was
sufficient power to detect differences greater than 5% in
response rates between relevant treatment groups (alpha
of .05/power at 80%) if the response rate was around 60%.
Procedure
The design was a two by two, factorial experiment, with
incentive amount ($3 vs. $5) and length of the survey
(short vs. long) as independent factors. The short version
contained 33 questions (10 pages), compared to 61 for the
long version (16 pages). The measures excluded from the
short version were similar in style and difficulty to those
that were retained.
The surveys were designed in Adobe InDesign and
printed in one color (blue) with tinting. A glossy cover
was added and the result was an   by 11-inch booklet.
The content of the surveys for each cancer was identical
except for minor wording changes to four of 61 questions.
The mailing procedures followed recommendations from
Dillman [15]. Procedures were approved by the Univer-
sity of Pennsylvania Institutional Review Board and the
Pennsylvania Cancer Registry.
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Each cancer patient was randomized to one of four
conditions: short survey, $3; short survey, $5; long survey,
$3 or long survey, $5. Randomization was conducted
using a random number generator in SPSS. Only the
research director had access to the master list. Each sub-
ject was assigned a code corresponding to one of the four
conditions. These codes were placed on the inside back
cover of the survey for identification upon their return.
For the incentives, 3 one-dollar bills or 1 five-dollar bill
were used. Questionnaire items were packaged by mem-
bers of the research team and other graduate research
assistants who signed confidentiality forms approved by
the IRB (as they would be seeing the names and addresses
on envelopes).
Mailing procedure
On September 1st, an introductory letter explaining that a
survey would be sent in a few days, and a brochure about
the Pennsylvania Cancer Registry was mailed. The letter
included information indicating that the respondent
could opt out of completing the survey, and providing
procedures for requesting to be dropped from the study.
On September 6th, the first copy of the survey, a second
letter, a business reply envelope, and the cash incentive
was mailed. The return of the mailed survey served as
evidence of consent.
Two weeks later, a reminder letter and another copy of
the survey (as well as a business reply envelope) were sent
to those from whom no survey had yet been received. No
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additional cash incentive was included with the third
mailing. All mailings were sent via first class mail, to
ensure timeliness.
Measures
Dependent variables
Overall response. Response rates were calculated four
months after the first mailing was sent (in early January),
using American Association for Public Opinion Research
(AAPOR) standard definitions [43]. For the experimental
analyses, AAPOR response rate 2 was used. It allows for
the inclusion of both complete and partial questionnaires.
Response rate 2 divides the number of questionnaires by
the number of refusals and non-refusals. It does not
include in the denominator cases that are known to be
ineligible -- those who were reported as deceased by a
family member (n = 22) or who contacted us to let us
know they did not have cancer (n = 27). However,
response rate 2 underestimates the true response rate by
an unknown amount. It includes in the denominator both
all cases which did not return the questionnaire and all
cases for whom the post office returned the question-
naires because the addressee was unknown. It is plausible
that some of those who did not respond were deceased.
To respond to this concern, an adjusted response rate was
calculated corresponding to AAPOR's response rate 4,
correcting the rate for those estimated to be ineligible to
respond, which, in this instance, is reduced by an esti-
mate of those likely to be deceased. Two sources of mor-
t a l i t y  w e r e  t a k e n  i n t o  a c c o u n t :  t h e  e x p e c t e d  m o r t a l i t y
from all causes given the age distribution of our sample
based on CDC published estimates [44], and the incre-
mental mortality specific to their cancer diagnosis and
stage. Cancer-specific incremental mortality estimates
were based on SEER data on 1- and 2-year survival rates
for each of the three cancers [40]. By interpolation, esti-
mates were derived for survival at 16 months, the mean
number of months between diagnosis and receipt of the
questionnaire (Estimated mortality: 5% for breast, 4% for
prostate and 21% for colon). These adjusted response
rates (RR4) are reported alongside RR2.
Statistical Analysis
Results of descriptive analyses presenting response rate
by demographic group are shown in Table 1. Summary
analyses (presented in Table 2) report RR2 for each con-
dition and RR4 for the three cancers and the total sample.
While the overall response rate can be adjusted on the
basis of assumptions about mortality among non-respon-
dents, more fine-grained analyses required assigning
each case to a response category. Thus, while overall
claims about response rates reflect RR4, experimental
analyses and demographic group comparisons focus only
on these respondents used also for response rate 2. Logis-
tic regression analyses determined the effect of survey
length, incentive amount, type of cancer, and interactions
among these variables on response rate (Table 3). All
regression analyses included three blocks. The first block,
the only one reported in Table 3, included the main
effects of incentive amount, length of survey, and type of
cancer (and for the demographic analyses, all of the
demographic variables). Type of cancer was dummy
coded with colon cancer patients serving as the compari-
son group. The second block added the two-way interac-
tions for incentive amount by length of survey, incentive
amount by type of cancer, and length of survey by type of
cancer (for the demographic analyses, all two-way inter-
actions between these variables and demographics). The
third block added the three-way interactions as a forced
entry block.
Post hoc analyses were conducted to determine
whether those receiving the long survey or the smaller
incentive skipped more items than those in the other con-
ditions. Also, for the 33 questions in the short survey,
respondents were compared by condition to see if the
quality of responses varied. Means and standard devia-
tions were computed for each condition and t-tests con-
ducted to check for significant differences. Additional
analyses test differences between responders and non-
responders using chi squares and non-parametric tests of
medians (for the age variable).
Results
Respondent characteristics
Demographics of respondent are presented in Table 1.
Response rates
The overall estimated RR4 response rate was 67%. The
average RR2 rate usable for the experimental analyses
across the 12 conditions was 62%, ranging from 42% for
colon cancer participants receiving $5 and the long sur-
vey to 72% for prostate cancer participants receiving $3
and the short survey (See Table 2).
Logistic regression analyses predicting RR2 response
rates revealed no significant differences between partici-
pants who received the $3 incentive and participants who
received the $5 incentive (OR = .99, p = 0.93) (see Table
3). There was a trend, but not a significant tendency for
the short survey length to achieve a higher response rate
(OR = .79, p = .06). However, type of cancer did influence
response rate. Colon cancer participants responded sig-
nificantly less often than both breast cancer and prostate
cancer participants (p  < .001 for both comparisons).
These differences were still significant when controlling
for age, race, marital status and stage of cancer. There
were no differences between breast cancer and prostate
cancer participants (OR = 1.15, p = .35). None of the two-
way interactions - between incentive amount by length;Kelly et al. BMC Medical Research Methodology 2010, 10:65
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incentive amount by type of cancer; type of cancer by
length of survey - nor the three-way interaction for type
of cancer by length of survey by amount of incentive were
significant (results not shown).
Demographics and cancer stage
Analyses revealed significant differences for age (p =
.002), race (p = .001), and stage of cancer (p = .001) on
response rate (see Table 4). Older individuals ( > =65
years) were less likely to respond than younger individu-
als ( < =64 years; response rates (RR2) were 58% and 67%,
respectively). Whites were more likely to respond than
non-Whites (RR2 = 64%, compared to 51%). Individuals
with metastatic cancer were significantly less likely to
respond (RR2 = 44%) than individuals at other stages
(RR2 = 66%). There were no significant interactions of
incentive amount or length with any of the demographic
variables.
Post hoc analyses
In order to assess non-response bias, we compared par-
ticipants who responded and participants who did not on
gender (for colon cancer only), age at diagnosis, marital
status, race and stage of cancer (see Table 5). Median age
for respondents and non-respondents was compared
using non-parametric tests of medians. Chi square analy-
ses were conducted for all other variables. The results
suggest that despite the high response rate, there were
some biases in the sample. This result led us to correct for
bias by oversampling stage 4 and African American
respondents for subsequent data collection.
Table 1: Demographic characteristics of respondents by condition
Short Long χ2, pval Total
D e m o g r a p h i c $ 3$ 5$ 3$ 5
Age, median (range) 68
(28-93)
68
(29-97)
66
(27-95)
66
(32-94)
67
(27-97)
Female, % 50.5% 53% 48% 50% 1.43, p < .70 50.5%
White race, % 88.8% 90.9% 91.6% 87.8% 25.09, p < .57 89.8%
Hispanic ethnicity, % 1.4% 1.4% 2.3% 1.7% 21.17, p < .27 1.9%
Married, % 62.2% 61.5% 65% 62.4% 13.91, p < .53 62.8%
Stage
1, % 19.9% 18.8% 21.6% 15.8% 11.97, p < .45 19%
2, % 45% 50% 50% 48% 48%
3, % 13.5% 13% 10% 18% 14%
4, % 9.4 7.4 6.8 7.3 7.7%
a N = 1150
Table 2: Response rates by incentive amount, length and cancer type
Incentive amount Colon
RR2
(RR4)
Breast
RR2
(RR4)
Prostate
RR2
(RR4)
Total
RR2
(RR4)
Short Long Short Long Short Long Short Long Total N
$3 50.6% 44.9% 69.7% 68.4% 71.6% 63.6% 64.3% 59.4% 61.8% 566
$5 52.1% 41.7% 70.7% 70.7% 69.1% 62.6% 64.1% 58.5% 61.3% 584
Total 47.3%a
(57.2%)
69.9%b
(73.3%)
66.7%b
(69.5%)
64.2% 58.9% 61.6%
(67%)
Number of usable surveys 368 392 390 573 577 1150
aResponse rates in parentheses are adjusted for estimated deaths, according to CDC and SEER data. Rates with different superscripts were 
significantly different from each other in logistic regression models.Kelly et al. BMC Medical Research Methodology 2010, 10:65
http://www.biomedcentral.com/1471-2288/10/65
Page 6 of 10
In addition, analyses were conducted to determine
whether survey length or level of incentive was associated
with quality of responses, including skipping more ques-
tions or answering questions differently. Only 18%
skipped any questions. Thus while there was a significant
difference by incentive amount in the proportion of peo-
ple who skipped any questions, the actual number
skipped in any condition was so low that there was no
practical concern about the difference. There were only
chance differences in substantive responses to the ques-
tions by incentive and length - examining response to the
33 questions in common across the four surveys.
Discussion
Overall, the results indicated that a small cash incentive
and appropriate recruitment procedures can produce
strong response rates to a lengthy mailed survey among
cancer patients. Our overall adjusted response rate was
67%. The rates we report here are slightly higher, but
comparable to some prior studies, which have achieved
response rates of 60-65% [45,46]. However, many of the
studies that have achieved the highest response rates have
used convenience samples or other non-representative
populations. In addition, this study was undertaken more
than 10 years after the referenced studies, a period when
Table 3: Results of logistic regression predicting response from incentive amount, survey length and type of cancer
Variable Results of logistic regression
B SE Wald Odds Ratio 95% CI p-value
Incentive ($3) -0.01 0.12 0.01 0.99 (0.78-1.25) 0.92
Survey Length (short) -0.23 0.12 3.48 0.79 (0.63-1.01) 0.06
Prostate cancer (Colon) 0.81 0.15 28.81 2.24 (1.68-3.02) < 0.01
Breast cancer (Colon) 0.95 0.15 39.26 2.59 (1.93-3.47) < 0.01
Constant 0.01 0.14 .01 1.01 (0.77-1.33) 0.92
Cox and Snell R2 0.043
an = 1150
b Reference category is in parentheses.
cSignificant differences in response for type of cancer hold when controlling for age, race, marital status and stage of cancer.
Table 4: Response rates (%) for demographic groups by condition
Variable Percentage of total Short/$3 Short/$5 Long/$3 Long/$5
Race (n = 1,150)
Non-white 6% 46.4 54.8 45.5 52.9
White 94% 63.8 63.1 57.3 58.8
Gender -colon cancer only (n = 399)
Female 53% 43.4 47.5 41.3 39.6
Male 47% 46.8 51.3 38.9 40.4
Age (n = 1,138)
> = 65 Years 54% 57.5 58.4 52.6 51.9
< = 64 Years 46% 66.1 67.8 60.6 65.6
Stage of cancer (N = 1036)
0 10.9% 65.6 55.6 73.1 64.3
I 19.3% 69.2 67.3 66.1 62.8
II 48.6% 70.4 71.6 65.1 68.2
III 13.8% 64.7 61.8 65.4 46.9
IV 7.3% 42.9 52.6 26.7 52.4
aNon-missing n = 1,031. Gender is only presented for colon cancer participants. Results of logistic regression models with interaction terms 
suggest that none of the variables interacted with condition.Kelly et al. BMC Medical Research Methodology 2010, 10:65
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a decline in response rates to all forms of surveys has
been a major concern of researchers. The achieved rate is
substantially higher than other studies have found for
mailed surveys in the last decade [13,37,47]. In a review
of 141 academic papers describing 175 separate studies
published in management and behavioral sciences in the
years 1975, 1985 and 1995, an average response rate of
55.6% was estimated [47]. Evidence that a mailed survey
drawing from a statewide registry in 2006 was able to
achieve this rate despite the reported declines in response
rates is noteworthy. The only parallel evidence we could
find for mailed cancer patient surveys comes from a study
in the Netherlands in 2005 using a single hospital's regis-
try, but it also achieved a response rate of 62% [48].
Interestingly, the amount of incentive ($3 versus $5)
was not a significant factor predicting response. In fact,
the response rates are virtually the same between partici-
pants who received $3 and participants who received $5.
The finding that the high response rate was received with
a relatively small incentive amount is encouraging for
future research.
While there was a tendency for the shorter question-
naire to earn a higher response rate, this was not a statis-
tically significant difference. This lack of significant
difference was surprising, given the drastic difference
between the two surveys. The post hoc results suggest
that length and incentive amount did not affect item
response either.
The adjusted response rates between breast cancer par-
ticipants and prostate cancer participants are comparable
(73% vs. 69.5%, respectively). However, colon cancer par-
ticipants responded at a lower rate (57%) than both breast
cancer and prostate cancer participants. The pattern
among the three cancers is consistent with the large
mixed mode ACS survey of survivors, for which 42% of
breast, 35% of prostate and 30% of colon cancer patients
responded [37]. This pattern of response may be partly
explained by the differential level of morbidity associated
with these cancers, which may affect ability to respond.
An alternative interpretation relies not on the actual
inability to respond but the emotions evoked by the sur-
veys. According to the Leverage-Saliency Theory of Sur-
vey Participation, the achieved influence of a particular
feature is a function of how important it is to the poten-
tial respondent, whether its influence is positive or nega-
tive, and how salient it becomes to the sample person
during the presentation of the survey request [49]. A sur-
vey which reminds a patient that he or she has a cancer
with relatively higher morbidity and less positive progno-
sis (colon cancer) may result in a lower response rate than
a survey about a cancer evoking emotions about a health
condition with a better prognosis (prostate or breast).
Similarly both of these explanations (actual inability
and psychological reluctance) may also explain why
p a t i e n t s  a t  m o r e  a d v a n c e d  s t a g e s  o f  d i s e a s e  w e r e  l e s s
likely to respond (45% for metastatic versus 66% for oth-
ers). Colon cancer patients were more likely to be at
higher stage at diagnosis (14% metastatic versus 5% for
breast and 2% for prostate).
The results by demographics provided some valuable
information for the sampling plan in the larger subse-
quent study. For example, because non-whites and those
with stage 4 cancers consistently responded less often
across conditions, those two groups were over-sampled
in order to ensure sufficient sub-group numbers for the
larger study. The lack of evidence for interactions
between demographics and condition were encouraging.
Table 5: Comparison of respondents and non-respondents on demographic characteristics
Colon cancer Prostate cancer Breast cancer Total
Responded? No Yes No Yes No Yes No Yes
Age
(median, SD)
73
(SD = 14)
70.5 (SD = 12) 67
(SD = 10)
68
(SD = 9)
64
(SD = 16)
60
(SD = 13)
70 (SD = 14) 66 (SD = 12)**
Gender
(% Female)
51% 53% NA NA NA
Stage 4 16% 13.5% 7% 2%* 10% 2.3%* 11.5% 5%
Race
(% white)
94% 95% 84% 93%* 89% 94% 90% 94%
Marital status
(% married)
45% 68%*** 70% 85%** 47% 62%* 53% 72%
aNon-missing n = 1150.
bSignificance testing for age was conducted using non-parametric tests of medians. For all other variables, significance testing was conducted 
using Chi square analyses. *Represent significant differences between respondents and non-respondents on a particular demographic variable. 
*p < .05; **p < .01; ***p < .001Kelly et al. BMC Medical Research Methodology 2010, 10:65
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Even if $3 and short surveys were used, the heterogeneity
of the sample would not be compromised.
The high rates of response despite secular declines in
response rates may have several explanations. Two possi-
ble explanations are discussed here: First, the procedures
followed those recommended by Dillman quite closely.
Second, these questionnaires were sent to cancer patients
who had been diagnosed in the previous calendar year.
This was a high salience issue for the patients. Also, the
questions that were asked were primarily about their
e x p e r i e n c e  i n  t ry i n g  t o  c h o o s e  t r e a t m e n t s  a n d  s u rv i v e
with their cancers, and about their use of public informa-
tion sources, as well as medical sources of information.
Respondents may have been appreciative of the opportu-
nity to discuss these topics.
These results are highly generalizable to other cancer
patient research contexts given the selection of a repre-
sentative sample and mailed survey implementation fol-
lowed standard recommended procedures, but subject to
the limitations described below.
Limitations
The study had several limitations. The fact that the study
lacked a $0 incentive control group means it is not possi-
ble to conclude that the incentive did not matter, only
that there was no difference between the effect of $3 vs.
$5 on response rates. The reason for the lack of difference
between the $3 and $5 conditions may be that the differ-
ence between the two amounts was too small to affect
behavior. Had the denominations been $2 and $6 or $0
and $5, there may have been a better chance of detecting
differences. A more systematic study would include sev-
eral different dollar amounts to test differences in the
effects between them. However, it is also important to
consider cost-effectiveness. For example, a higher dollar
amount might result in a slightly higher response rate,
but the increase may not justify the additional cost.
Future research should investigate the incremental costs
per questionnaire returned.
It is possible that the lack of differences reflect cancer
patients' sense of altruism or the need to try to give some-
thing back to others who might be going through a simi-
lar experience. In addition, we know that salience of the
survey topic increases the likelihood for response [49].
Leverage-Salience Theory can again explain these find-
ings. In this case, the salience of the survey topic may
have been more important than any incentive amount
and, thus, diminished the effect of the incentive.
A second limitation is that both response rates exclude
twenty-seven people who called or sent letters to say they
did not have cancer. It is plausible that some patients who
truly do have cancer may deny it, may consider their con-
ditions pre-cancerous (such as those with stage 0 colon
cancer or ductal carcinoma in situ). It is also possible that
some patients may have been mistakenly reported to the
PCR (misdiagnosed). In fact, those designated by the
PCR as having a Stage 0 cancer did respond at a slightly
lower rate than those with stage 1 and stage 2 cancers
(58% compared to 65% and 67%, though this was not a
significant difference). It is impossible to determine
whether any of these people denying the cancer diagnosis
may have been misclassified as ineligible. However, this
group is 2% of the total sample and thus the effect on the
substantive results reported here is negligible.
Despite the high response rates, there is a strong possi-
bility that those least likely to respond to a survey regard-
ing cancer are the people who have fared the poorest in
terms of their treatment or who have had the most nega-
tive experiences. Groves et al. (2006) write that salience
does not always have a positive effect: "When the topic of
the survey ... generates negative thoughts, unpleasant
memories or reminders of embarrassing personal failings,
then the topic may suppress participation despite its per-
sonal relevance [3]." When the reasons for non-response
are correlated with variables within the survey, non-
response bias represents a significant threat to validity.
However, the relatively high response rates overall help
provide confidence that those biases have been mini-
mized and that a fairly representative sample of the Penn-
sylvania patient population with these three types of
cancer has been included. The lower response rate from
stage 4 patients may be an exception to this claim.
Conclusions
As telephone surveys continue to achieve low response
rates and until Web methods can reach a less biased sam-
ple, particularly of older and poorer populations, and call
on appropriate sampling frames of internet addresses for
cancer patients, mailed surveys might provide a promis-
ing alternative for reaching cancer patients. The evidence
from the survey presented here suggests that even when
the burden of questions is high and the incentive amount
is small (just $3), high response rates can be achieved.
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